Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q1 2026 (March 31)4holders
0new positions
0sold out
$12.98avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($6K), PNC Financial Services Group, Inc. ($6K) and GAMMA Investing LLC ($2K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 157 shares bought and 651 shares sold, net −494 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Rhumbline Advisers | 0.00% | Reduce -58.6% | 456 | $6K |
| PNC Financial Services Group, Inc. | 0.00% | Add +54.7% | 444 | $6K |
| GAMMA Investing LLC | 0.00% | No change | 182 | $2K |
| IMA Advisory Services, Inc. | 0.00% | Reduce -17.6% | 28 | $363 |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.